Anticoagulant News and Research

RSS
Patients at greatest risk of post-PCI bleeding least likely to receive bleeding avoidance strategies

Patients at greatest risk of post-PCI bleeding least likely to receive bleeding avoidance strategies

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

Routine cessation of clopidogrel in patients before colonoscopy polypectomy not necessary: Researchers

Routine cessation of clopidogrel in patients before colonoscopy polypectomy not necessary: Researchers

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

Phase 1B/2 clinical study to evaluate efficacy of PMX-60056 in reversing heparin levels initiated

Phase 1B/2 clinical study to evaluate efficacy of PMX-60056 in reversing heparin levels initiated

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Clinical testing service for safer dosing of warfarin

Clinical testing service for safer dosing of warfarin

Results of M118 EMINENCE clinical trial published in Circulation

Results of M118 EMINENCE clinical trial published in Circulation

FamilyCord acquires assets of Vista Cord

FamilyCord acquires assets of Vista Cord

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Phase 1B clinical study initiated to evaluate safety and efficacy of PMX-60056

Phase 1B clinical study initiated to evaluate safety and efficacy of PMX-60056

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics' personal Genetic Health Report now available

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.